ArticleFrontiers in oncology2026

Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT.

Tengfei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.